Related Experiment Videos
Rapid molecular theranostics in infectious diseases.
François J Picard1, Michel G Bergeron
1Centre de Recherche en Infectiologie de l'Université Laval, Centre Hospitalier Universitaire de Québec, Pavillon CHUL, 2705 Boulevard Laurier, Québec, Canada, G1V 4G2.
Drug Discovery Today
|January 28, 2003
Summary
Rapid molecular diagnostic assays are transforming infectious disease medicine, moving beyond slow culture methods. This review covers essential conditions and quality control for developing these advanced molecular theranostic tools.
Area of Science:
- Microbiology
- Molecular Biology
- Infectious Diseases
Background:
- Traditional culture-based methods for infectious diseases are time-consuming, often taking over two days.
- The increasing availability of rapid and sensitive nucleic acid testing offers a significant advancement.
Purpose of the Study:
- To review the essential conditions and quality control measures for developing and validating molecular theranostic assays in infectious diseases.
- To highlight the emerging concept of molecular theranostics for improved patient management and antimicrobial stewardship.
Main Methods:
- Review of current literature on nucleic acid testing and molecular diagnostics.
- Analysis of requirements for assay development and validation.
- Discussion of quality control frameworks for molecular theranostic assays.
Main Results:
- Molecular theranostics utilize molecular biology tools for rapid, accurate infectious disease diagnosis.
- These assays enable better initial patient management and optimize antimicrobial use.
- Essential conditions and quality control are critical for reliable assay performance.
Conclusions:
- Molecular theranostic assays are poised to revolutionize infectious disease diagnostics.
- Adherence to stringent development and validation protocols is crucial.
- This approach promises enhanced patient care and improved antimicrobial stewardship.